These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34867944)

  • 21. Seropositivity-Dependent Association between LINE-1 Methylation and Response to Methotrexate Therapy in Early Rheumatoid Arthritis Patients.
    Ravaei A; Pulsatelli L; Assirelli E; Meliconi R; Ciaffi J; Gremese E; Tolusso B; Salvarani C; Govoni M; Rubini M
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
    Palmowski A; Strehl C; Pfeiffenberger M; Häupl T; Schad M; Kallarackal J; Prothmann U; Dammann D; Bonin M; Brandt A; Schneider U; Gaber T; Buttgereit F
    Clin Rheumatol; 2024 Jan; 43(1):511-519. PubMed ID: 37978145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The induction of apoptosis by methotrexate in activated lymphocytes as indicated by fluorescence hyperpolarization: a possible model for predicting methotrexate therapy for rheumatoid arthritis patients.
    Herman S; Zurgil N; Langevitz P; Ehrenfeld M; Deutsch M
    Cell Struct Funct; 2003 Apr; 28(2):113-22. PubMed ID: 12808231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
    Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
    Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous Developmental and Early Life Trichloroethylene Exposure Promoted DNA Methylation Alterations in Polycomb Protein Binding Sites in Effector/Memory CD4
    Byrum SD; Washam CL; Patterson JD; Vyas KK; Gilbert KM; Blossom SJ
    Front Immunol; 2019; 10():2016. PubMed ID: 31555266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate increases expression of cell cycle checkpoint genes via JNK activation.
    Spurlock CF; Tossberg JT; Fuchs HA; Olsen NJ; Aune TM
    Arthritis Rheum; 2012 Jun; 64(6):1780-9. PubMed ID: 22183962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
    van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of Ramucirumab and methotrexate co-therapy in rheumatoid arthritis experimental model: Involvement of angiogenic and immunomodulatory signaling.
    Abdel-Maged AE; Gad AM; Wahdan SA; Azab SS
    Toxicol Appl Pharmacol; 2019 Oct; 380():114702. PubMed ID: 31398424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4+ T cell subpopulations.
    Herman S; Zurgil N; Langevitz P; Ehrenfeld M; Deutsch M
    Immunol Invest; 2004 Aug; 33(3):351-62. PubMed ID: 15495793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
    Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
    Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
    Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.
    Blits M; Jansen G; Assaraf YG; van de Wiel MA; Lems WF; Nurmohamed MT; van Schaardenburg D; Voskuyl AE; Wolbink GJ; Vosslamber S; Verweij CL
    Arthritis Rheum; 2013 Nov; 65(11):2791-802. PubMed ID: 23897011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
    Wessels JA; van der Kooij SM; le Cessie S; Kievit W; Barerra P; Allaart CF; Huizinga TW; Guchelaar HJ;
    Arthritis Rheum; 2007 Jun; 56(6):1765-75. PubMed ID: 17530705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients.
    Gosselt HR; van Zelst BD; de Rotte MCFJ; Hazes JMW; de Jonge R; Heil SG
    Arthritis Res Ther; 2019 Jun; 21(1):157. PubMed ID: 31242943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis].
    Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP
    Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate.
    Kotrych D; Dziedziejko V; Safranow K; Pawlik A
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3037-40. PubMed ID: 26367725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients.
    Heinicke F; Zhong X; Flåm ST; Breidenbach J; Leithaug M; Mæhlen MT; Lillegraven S; Aga AB; Norli ES; Mjaavatten MD; Haavardsholm EA; Zucknick M; Rayner S; Lie BA
    Front Immunol; 2021; 12():663736. PubMed ID: 33897713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate inhibits NF-κB activity via long intergenic (noncoding) RNA-p21 induction.
    Spurlock CF; Tossberg JT; Matlock BK; Olsen NJ; Aune TM
    Arthritis Rheumatol; 2014 Nov; 66(11):2947-57. PubMed ID: 25077978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.